Health ❯Healthcare

Regulatory Agencies

FDA European Medicines Agency Drug Approval Process NHS Drug Approval UK Regulatory Agency UK Drug Approval Drug Licensing ANSM Health Inspections Drug Guidelines CDC and FDA Regional Health Agencies UK Swissmedic MHRA Medical Devices Drug Approvals Food and Drug Administration Drug Safety Approval Process

FDA Recalls Acne Treatments Over Benzene Contamination

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

NHS England Faces Concerns Over MS Drug Switch After Reports of Severe Side Effects

France to Reform Foreign Doctor Certification as 3,800 Admitted in 2024

Systane Eye Drops Recalled Over Potential Fungal Contamination

Systane Eye Drops Recalled Nationwide Over Fungal Contamination Risk

FDA Recalls Over 233,000 Bottles of Antidepressant Duloxetine for Cancer-Causing Impurity

France Restricts Sale of Eight Popular Cold Medications Over Safety Concerns

Clonazepam Recalled Nationwide Over Potentially Life-Threatening Labeling Error

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

FDA Faces Uncertain Future with Trump's Return and RFK Jr.'s Influence

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

UK Regulators Warn Against Misuse of Weight-Loss Injections

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Critical IV Fluid Shortage Disrupts US Hospitals

FDA Mandates Breast Density Information in Mammogram Reports

New Studies Confirm Safety of Semaglutide for Mental Health

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs

New Study Links Ozempic to Increased Risk of Suicidal Thoughts

New Study Fuels Debate on Semaglutide's Mental Health Risks

FDA Declines MDMA for PTSD Treatment, Requests Further Trials

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections

EU Regulator Denies Approval for Alzheimer's Drug Lecanemab

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients